Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genetic determinants of recurrent somatic mutations in 43,693 blood genomes.

Science advances·2023
Same author

Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.

Nature·2023
Same author

Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications.

medRxiv : the preprint server for health sciences·2023
Same author

Structural variation across 138,134 samples in the TOPMed consortium.

Research square·2023
Same author

Bioinformatics Analysis Reveals a Shared Pathway for Common Forms of Adult Nephrotic Syndrome.

Kidney360·2023
Same author

Structural variation across 138,134 samples in the TOPMed consortium.

bioRxiv : the preprint server for biology·2023

Related Experiment Video

Updated: Jul 14, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

An update on pruritus associated with CKD.

Tejesh S Patel1, Barry I Freedman, Gil Yosipovitch

  • 1Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|June 27, 2007
PubMed
Summary

Chronic kidney disease (CKD) and end-stage renal disease prevalence is rising globally. CKD-associated pruritus significantly impacts patient quality of life and outcomes, yet remains underrecognized and undertreated.

Related Experiment Videos

Last Updated: Jul 14, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

  • Nephrology
  • Dermatology
  • Public Health

Background:

  • Global rise in chronic kidney disease (CKD) and end-stage renal disease.
  • CKD-associated pruritus is a prevalent, distressing symptom impacting quality of life and patient outcomes.
  • Inadequate recognition and management of CKD-associated pruritus by healthcare professionals.

Purpose of the Study:

  • Highlight the significance of CKD-associated pruritus as a neglected topic.
  • Provide an overview of current knowledge on CKD-associated pruritus.
  • Summarize recent epidemiological data, outcomes, mechanisms, and treatments.

Main Methods:

  • Review of recent epidemiological studies.
  • Analysis of outcomes data related to CKD-associated pruritus.
  • Exploration of proposed pathophysiological mechanisms.
  • Examination of emerging treatment options.

Main Results:

  • CKD-associated pruritus negatively affects patient quality of life and sleep.
  • Evidence links pruritus to poorer patient outcomes in CKD.
  • Pathophysiological mechanisms of pruritus in CKD are not well-defined.
  • Development of targeted therapies remains challenging.

Conclusions:

  • CKD-associated pruritus is a significant public health issue requiring greater attention.
  • Further research into mechanisms and treatments is crucial for improved patient care.
  • Multidisciplinary approaches are needed to effectively manage this symptom.